Journal
CELL BIOCHEMISTRY AND BIOPHYSICS
Volume 70, Issue 2, Pages 1357-1362Publisher
HUMANA PRESS INC
DOI: 10.1007/s12013-014-0064-8
Keywords
Quercetin; Rituximab; STAT3; DLBCL
Ask authors/readers for more resources
STAT3 pathway plays an important role in the growth of diffuse large B-cell lymphoma (DLBCL) cells. Here we investigated the antitumor activity of Quercetin, a flavonoid compound, in combination with rituximab in DLBCL cell lines in vitro. We found that Quercetin synergistically enhanced rituximab-induced growth inhibition and apoptosis in DLBCL cell lines. Moreover, we found Quercetin exerted inhibitory activity against STAT3 pathway and downregulated the expression of survival genes. These results suggest that combining the Quercetin with rituximab may present an attractive and potentially effective way for the treatment of DLBCL.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available